ANTI-ORAI1 ANTIBODY

The purpose of the present invention is to provide a therapeutic and/or prophylactic agent, said agent targeting human Orai1, for transplant rejection, immunopathies, allergic diseases, inflammatory diseases, thrombi, cancers, etc. Provided are a medicinal composition, etc. comprising an antibody th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KIMURA, TAKAKO, AKI, ANRI, TANAKA, KENTO, ONODERA, YOSHIKUNI, NAGAOKA, NOBUMI, KAGARI, TAKASHI, BABA, DAICHI, KOMAI, TOMOAKI
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The purpose of the present invention is to provide a therapeutic and/or prophylactic agent, said agent targeting human Orai1, for transplant rejection, immunopathies, allergic diseases, inflammatory diseases, thrombi, cancers, etc. Provided are a medicinal composition, etc. comprising an antibody that has an activity of specifically recognizing human Orai1 and suppressing human T cell activation. L'objectif de la présente invention est de fournir un agent thérapeutique et/ou prophylactique, ledit agent ciblant Orai1 humain, pour éviter le rejet de greffe, les immunopathies, les maladies allergiques, les maladies inflammatoires, les cancers, les thrombus, etc L'invention concerne une composition médicinale, etc. comprenant un anticorps qui possède une activité de reconnaissance spécifique de Orai1 humain et de suppression de l'activation des lymphocytes T humains.